44 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. The Company also provides laboratory services
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. The Company also provides
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
19 Jul 23
Regulation FD Disclosure
9:21am
, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation of diagnostic testing, utilizing proprietary
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am
progress this past year, our goal for 2022 is to focus on our core programs to drive innovation and bring about advanced technologies and new medicines
8-K
EX-99.1
itbt trcgv4h5fizj
2 May 22
Regulation FD Disclosure
4:00pm
8-K
hd1y0v 9qwjtyxe
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
goc9jukt3
14 Jun 21
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
9:12am
DEFA14A
EX-99.1
doswhqsh16d91i1705o
14 Jun 21
Additional proxy soliciting materials
9:10am
424B3
syzcia38
29 Jun 23
Prospectus supplement
4:31pm
424B2
mj8 5qmi8
26 Apr 19
Prospectus for primary offering
5:07pm
424B4
21fqfek8z68x
14 Aug 18
Prospectus supplement with pricing info
12:18pm